CBAY Historical PE Ratio image   This CBAY PE ratio history page last updated 11/15/2022
CBAY PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/14/2022
3.61-0.28-1.25NA
Q2 2022
8/11/2022
3.74-0.31-1.30NA
Q1 2022
5/12/2022
1.78-0.32-1.33NA
Q4 2021
3/17/2022
3.18-0.34-1.26NA
Q3 2021
11/10/2021
4.28-0.33-1.15NA
Q2 2021
8/12/2021
3.96-0.34-0.99NA
Q1 2021
5/13/2021
4.12-0.25-0.81NA
Q4 2020
3/25/2021
4.59-0.23-0.75NA
Q3 2020
11/5/2020
8.50-0.17-0.95NA
Q2 2020
8/10/2020
6.90-0.16-1.16NA
Q1 2020
5/11/2020
1.84-0.19-1.35NA
Q4 2019
3/12/2020
1.41-0.43-1.53NA
Q3 2019
11/5/2019
5.19-0.38-1.42NA
Q2 2019
8/7/2019
5.56-0.35-1.38NA
Q1 2019
5/8/2019
12.75-0.37-1.33NA
Q4 2018
2/28/2019
11.81-0.32-1.28NA
Q3 2018
11/6/2018
10.91-0.34-1.07NA
Q2 2018
8/9/2018
11.64-0.30-0.94NA
Q1 2018
5/8/2018
12.30-0.32-0.95NA
Q4 2017
3/15/2018
12.49-0.11-0.83NA
Q3 2017
11/8/2017
8.33-0.21-1.02NA
Q2 2017
8/10/2017
6.66-0.31-1.06NA
Q1 2017
5/11/2017
3.62-0.20-1.05NA
Q4 2016
3/23/2017
3.81-0.30-1.14NA
Q3 2016
11/9/2016
1.45-0.25-1.10NA
Q2 2016
8/9/2016
1.79-0.30NANA
Q1 2016
5/11/2016
2.40-0.29NANA
Q4 2015
3/29/2016
1.41-0.26NANA
CBAY Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/14/2022
3.61-0.28-1.12NA
Q2 2022
8/11/2022
3.74-0.31-1.24NA
Q1 2022
5/12/2022
1.78-0.32-1.28NA
Q4 2021
3/17/2022
3.18-0.34-1.36NA
Q3 2021
11/10/2021
4.28-0.33-1.32NA
Q2 2021
8/12/2021
3.96-0.34-1.36NA
Q1 2021
5/13/2021
4.12-0.25-1.00NA
Q4 2020
3/25/2021
4.59-0.23-0.92NA
Q3 2020
11/5/2020
8.50-0.17-0.68NA
Q2 2020
8/10/2020
6.90-0.16-0.64NA
Q1 2020
5/11/2020
1.84-0.19-0.76NA
Q4 2019
3/12/2020
1.41-0.43-1.72NA
Q3 2019
11/5/2019
5.19-0.38-1.52NA
Q2 2019
8/7/2019
5.56-0.35-1.40NA
Q1 2019
5/8/2019
12.75-0.37-1.48NA
Q4 2018
2/28/2019
11.81-0.32-1.28NA
Q3 2018
11/6/2018
10.91-0.34-1.36NA
Q2 2018
8/9/2018
11.64-0.30-1.20NA
Q1 2018
5/8/2018
12.30-0.32-1.28NA
Q4 2017
3/15/2018
12.49-0.11-0.44NA
Q3 2017
11/8/2017
8.33-0.21-0.84NA
Q2 2017
8/10/2017
6.66-0.31-1.24NA
Q1 2017
5/11/2017
3.62-0.20-0.80NA
Q4 2016
3/23/2017
3.81-0.30-1.20NA
Q3 2016
11/9/2016
1.45-0.25-1.00NA
Q2 2016
8/9/2016
1.79-0.30-1.20NA
Q1 2016
5/11/2016
2.40-0.29-1.16NA
Q4 2015
3/29/2016
1.41-0.26-1.04NA
Quotes delayed 20 minutes

Email EnvelopeFree CBAY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CymaBay Therapeutics (CBAY) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CBIO PE Ratio History
CCCC PE Ratio History
CCEL PE Ratio History
CCRN PE Ratio History
CCXI PE Ratio History
CDAK PE Ratio History
CDMO PE Ratio History
CDNA PE Ratio History
CDRE PE Ratio History
CDTX PE Ratio History
On this page we presented the CBAY PE Ratio History information for CymaBay Therapeutics' stock. The average CBAY PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CBAY PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CBAY PE ratio history result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for CBAY had been 3.61, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on CBAY or any other given stock, valuation analysis for CBAY can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate CymaBay Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for CBAY. Thanks for visiting, and the next time you need to research CBAY PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: BMAQ Insider Buying, HON Options Chain, Institutional Holders of GNTA.

 

CBAY PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.